乳腺良性疾病與乳腺癌風險_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 呂青 ¹ , 瞿亞軍 ²

1. ;
2. ;

Corresponding?author：

呂青, Email: lqlq1963@163.com

Keywords：

DOI：

10.7507/1007-9424.202010025

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 呂青, 瞿亞軍. 乳腺良性疾病與乳腺癌風險. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(11): 1329-1333. doi: 10.7507/1007-9424.202010025 Copy

1.	Silverstein M. Where’s the outrage? J Am Coll Surg, 2009, 208(1): 78-79.
2.	Visscher DW, Frost MH, Hartmann LC, et al. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer, 2016, 122(3): 378-385.
3.	宋豐舉, 劉雪鷗, 黃育北, 等. 中國女性良性乳腺疾病的流行現狀、危險因素及對乳腺癌篩查效果的影響研究. 成都: 全國腫瘤流行病學和腫瘤病因學學術會議論文集, 2015.
4.	新浪網. 中國人口協會發布中國乳腺疾病調查報告. 2010 年 2 月 1 日. http://eladies.sina.com.cn/nx/2010/0201/1059966477.shtml.
5.	London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA, 1992, 267(7): 941-944.
6.	Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med, 2005, 353(3): 229-237.
7.	Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med, 1985, 312(3): 146-151.
8.	Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst, 1989, 81(24): 1879-1886.
9.	Zeinomar N, Phillips KA, Daly MB, et al. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort. Int J Cancer, 2019, 145(2): 370-379.
10.	Wang Y, Gao Y, Battsend M, et al. Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for Chinese women. Tumour Biol, 2014, 35(11): 10861-10869.
11.	Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer, 1993, 71(4): 1258-1265.
12.	Salamat F, Niakan B, Keshtkar A, et al. Subtypes of benign breast disease as a risk factor of breast cancer: a systematic review and meta analyses. Iran J Med Sci, 2018, 43(4): 355-364.
13.	Wang J, Costantino JP, Tan-Chiu E, et al. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst, 2004, 96(8): 616-620.
14.	Cheng J, Qiu S, Raju U, et al. Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat, 2008, 111(2): 289-296.
15.	Worsham MJ, Raju U, Lu M, et al. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res, 2007, 13(18 Pt 1): 5474-5479.
16.	Jacobs TW, Byrne C, Colditz G, et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med, 1999, 340(6): 430-436.
17.	Linell F, Ljungberg O, Andersson I. Breast carcinoma. Aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand Suppl, 1980, (272): 1-233.
18.	Fisher ER, Palekar AS, Sass R, et al. Scar cancers: pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) - IX. Breast Cancer Res Treat, 1983, 3(1): 39-59.
19.	Andersen JA, Carter D, Linell F. A symposium on sclerosing duct lesions of the breast. Pathol Annu, 1986, 21 Pt 2: 145-179.
20.	Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology, 1993, 23(3): 225-231.
21.	Nassar A, Visscher DW, Degnim AC, et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res Treat, 2015, 153(2): 397-405.
22.	Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med, 1994, 331(1): 10-15.
23.	Sklair-Levy M, Sella T, Alweiss T, et al. Incidence and management of complex fibroadenomas. AJR Am J Roentgenol, 2008, 190(1): 214-218.
24.	El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer. Breast, 2003, 12(5): 302-307.
25.	Dorjgochoo T, Deming SL, Gao YT, et al. History of benign breast disease and risk of breast cancer among women in China: a case-control study. Cancer Causes Control, 2008, 19(8): 819-828.
26.	Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol, 2006, 30(6): 665-672.
27.	Ali-Fehmi R, Carolin K, Wallis T, et al. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol, 2003, 34(3): 234-239.
28.	Santen RJ, Mansel R. Benign breast disorders. N Engl J Med, 2005, 353(3): 275-285.
29.	Jensen RA, Page DL, Dupont WD, et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer, 1989, 64(10): 1977-1983.
30.	Shaaban AM, Sloane JP, West CR, et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol, 2002, 26(4): 421-430.
31.	Visscher DW, Nassar A, Degnim AC, et al. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat, 2014, 144(1): 205-212.
32.	Said SM, Visscher DW, Nassar A, et al. Flat epithelial atypia and risk of breast cancer: A Mayo cohort study. Cancer, 2015, 121(10): 1548-1555.

1. Silverstein M. Where’s the outrage? J Am Coll Surg, 2009, 208(1): 78-79.
2. Visscher DW, Frost MH, Hartmann LC, et al. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer, 2016, 122(3): 378-385.
3. 宋豐舉, 劉雪鷗, 黃育北, 等. 中國女性良性乳腺疾病的流行現狀、危險因素及對乳腺癌篩查效果的影響研究. 成都: 全國腫瘤流行病學和腫瘤病因學學術會議論文集, 2015.
4. 新浪網. 中國人口協會發布中國乳腺疾病調查報告. 2010 年 2 月 1 日. http://eladies.sina.com.cn/nx/2010/0201/1059966477.shtml.
5. London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA, 1992, 267(7): 941-944.
6. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med, 2005, 353(3): 229-237.
7. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med, 1985, 312(3): 146-151.
8. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst, 1989, 81(24): 1879-1886.
9. Zeinomar N, Phillips KA, Daly MB, et al. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort. Int J Cancer, 2019, 145(2): 370-379.
10. Wang Y, Gao Y, Battsend M, et al. Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for Chinese women. Tumour Biol, 2014, 35(11): 10861-10869.
11. Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer, 1993, 71(4): 1258-1265.
12. Salamat F, Niakan B, Keshtkar A, et al. Subtypes of benign breast disease as a risk factor of breast cancer: a systematic review and meta analyses. Iran J Med Sci, 2018, 43(4): 355-364.
13. Wang J, Costantino JP, Tan-Chiu E, et al. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst, 2004, 96(8): 616-620.
14. Cheng J, Qiu S, Raju U, et al. Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat, 2008, 111(2): 289-296.
15. Worsham MJ, Raju U, Lu M, et al. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res, 2007, 13(18 Pt 1): 5474-5479.
16. Jacobs TW, Byrne C, Colditz G, et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med, 1999, 340(6): 430-436.
17. Linell F, Ljungberg O, Andersson I. Breast carcinoma. Aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand Suppl, 1980, (272): 1-233.
18. Fisher ER, Palekar AS, Sass R, et al. Scar cancers: pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) - IX. Breast Cancer Res Treat, 1983, 3(1): 39-59.
19. Andersen JA, Carter D, Linell F. A symposium on sclerosing duct lesions of the breast. Pathol Annu, 1986, 21 Pt 2: 145-179.
20. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology, 1993, 23(3): 225-231.
21. Nassar A, Visscher DW, Degnim AC, et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res Treat, 2015, 153(2): 397-405.
22. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med, 1994, 331(1): 10-15.
23. Sklair-Levy M, Sella T, Alweiss T, et al. Incidence and management of complex fibroadenomas. AJR Am J Roentgenol, 2008, 190(1): 214-218.
24. El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer. Breast, 2003, 12(5): 302-307.
25. Dorjgochoo T, Deming SL, Gao YT, et al. History of benign breast disease and risk of breast cancer among women in China: a case-control study. Cancer Causes Control, 2008, 19(8): 819-828.
26. Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol, 2006, 30(6): 665-672.
27. Ali-Fehmi R, Carolin K, Wallis T, et al. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol, 2003, 34(3): 234-239.
28. Santen RJ, Mansel R. Benign breast disorders. N Engl J Med, 2005, 353(3): 275-285.
29. Jensen RA, Page DL, Dupont WD, et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer, 1989, 64(10): 1977-1983.
30. Shaaban AM, Sloane JP, West CR, et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol, 2002, 26(4): 421-430.
31. Visscher DW, Nassar A, Degnim AC, et al. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat, 2014, 144(1): 205-212.
32. Said SM, Visscher DW, Nassar A, et al. Flat epithelial atypia and risk of breast cancer: A Mayo cohort study. Cancer, 2015, 121(10): 1548-1555.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

乳腺良性疾病與乳腺癌風險

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content